Call for Papers
Journal of Advanced Pharmaceutical Science and Technology (JAPST) invites high quality research that advances drug discovery, pharmaceutics, clinical pharmacy, regulatory science, and translational therapeutics. Publish open access and reach a global audience of researchers, clinicians, and industry experts.
A home for impactful pharmaceutical science
JAPST is a peer reviewed, open access journal focused on innovative pharmaceutical research with real world impact. We welcome studies that move from bench to bedside, optimize therapies, or introduce new platforms for drug delivery and formulation. Our editorial team prioritizes scientific rigor, translational relevance, and clear reporting.
If your work addresses pharmacology, pharmaceutics, pharmaceutical analysis, clinical outcomes, or regulatory science, we encourage you to submit. We publish original research, reviews, short communications, methods, case based insights, and policy focused perspectives.
Our audience spans academic researchers, clinical pharmacists, biotechnology innovators, and regulatory professionals. This mix ensures that your work reaches both scientific peers and decision makers who translate findings into patient care, manufacturing, and public health impact.
Journal at a glance
ISSN: 2328-0182 | DOI prefix: 10.14302/issn.2328-0182 | License: CC BY 4.0 | Open access publishing
Publishing standards and ethics
JAPST follows international publication ethics and emphasizes transparency at every stage. We evaluate novelty, methodological rigor, reproducibility, and clinical or technological relevance. We welcome interdisciplinary collaborations that combine laboratory science with clinical or real world evidence and responsible data sharing. Authors are expected to provide clear disclosures, data availability statements, and ethical approvals where required.
We screen manuscripts for originality, scope fit, and research integrity before peer review. This helps reviewers focus on scientific value and improves time to decision for authors.
- Ethical approval and informed consent are required for human and animal studies.
- Conflicts of interest, funding sources, and author contributions must be disclosed.
- Data and code availability statements improve reproducibility and citation potential.
Priority research areas
We invite submissions across the full pharmaceutical pipeline. Topics of interest include, but are not limited to:
Drug discovery and development
Lead identification, target validation, medicinal chemistry, pharmacodynamics, and pharmacokinetics.
Drug delivery and formulation
Nanomedicine, controlled release systems, biologics delivery, stability, and bioavailability optimization.
Clinical pharmacy and outcomes
Therapeutic drug monitoring, pharmacovigilance, adherence, and real world effectiveness studies.
Pharmaceutical analysis
Analytical methods, bioanalytical validation, quality control, and regulatory compliant testing.
Regulatory and policy science
Regulatory strategy, quality by design, biosimilar development, and market access research.
Translational and interdisciplinary studies
Bioinformatics for drug design, AI driven discovery, pharmacogenomics, and precision medicine.
For detailed scope coverage, visit the Aims and Scope page.
Article types we publish
Choose the manuscript type that best fits your study goals and contribution.
Original research
Full length reports presenting novel data, robust methodology, and validated conclusions.
Systematic reviews and meta analyses
Evidence syntheses that follow established reporting frameworks and provide decision ready insights.
Short communications
Concise reports of time sensitive findings, pilot results, or technical advances.
Methods and protocols
Validated assays, workflows, and analytical techniques that improve reproducibility.
Clinical and real world evidence
Studies focused on patient outcomes, safety, and therapeutic impact in practice.
Perspectives and policy analysis
Thought leadership on regulation, access, and the future of pharmaceutical innovation.
Why publish with JAPST
- Open access publishing with global visibility and immediate accessibility for practitioners and industry partners.
- Rigorous peer review by specialists who understand pharmaceutical science, technology, and clinical application.
- Rapid and transparent editorial decisions with clear communication at every stage.
- Professional production, DOI assignment, and metadata that supports long term discoverability.
- Author centered support from pre submission inquiries to final proof review.
- Opportunities to contribute to themed collections and special issues that shape emerging fields.
Visibility and impact
Every article receives a DOI and is published under a CC BY 4.0 license, enabling broad reuse and citation. Open access distribution means your findings are available to clinicians, researchers, industry teams, and policy makers without subscription barriers. We maintain high quality metadata to support discovery across search engines, academic databases, and institutional repositories.
To strengthen reach, we recommend clear titles, structured abstracts, and focused keywords. Linking to data, code, or protocol repositories also improves visibility and reuse. JAPST promotes published work through journal alerts and topical collections when appropriate.
Editorial workflow
Our process balances speed with quality assurance. Each submission receives a scope check, editorial screening, and expert peer review. Authors receive clear guidance on revisions and final decisions.
- Initial screening: Scope fit, ethics compliance, and completeness review.
- Peer review: Subject experts assess methodology, novelty, and impact.
- Decision and revision: Clear editorial recommendations to strengthen the work.
- Production: Copyediting, DOI assignment, and online publication.
What makes a strong submission
High performing manuscripts are clear, reproducible, and tied to meaningful pharmaceutical outcomes. We value robust experimental design, appropriate statistics, and a concise narrative that highlights why the work matters to science and practice.
- Well defined research questions and clinically or technologically relevant endpoints.
- Transparent methods with enough detail for replication and validation.
- Results supported by appropriate controls and analysis.
- Discussion that explains impact, limitations, and next steps.
- Figures and tables that tell the story without redundancy.
Submission pathway
Submit manuscripts using one of the approved routes below. Please indicate "JAPST" and your intended manuscript type in the cover letter.
- Manuscript Zone: https://oap.manuscriptzone.net
- Online submission form: https://openaccesspub.org/manuscript-submission-form
- Email submission: [email protected]
For detailed formatting guidance, visit the Instructions for Author page.
What happens after submission
You will receive a manuscript acknowledgment within 72 hours of submission. After editorial screening, submissions proceed to peer review and receive a clear decision with reviewer feedback. Decisions include accept, minor revision, major revision, or reject. Our goal is to provide actionable guidance that helps authors strengthen their work and move efficiently toward publication.
Special issues and themed collections
JAPST publishes special issues that spotlight high priority topics in pharmaceutical science and technology. These collections are curated by guest editors and often attract focused readership, higher engagement, and strong citation visibility.
If you have a proposal for a special issue or would like to submit to an active theme, review the Proposed Special Issue and Ongoing Special Issue pages.
Before you submit
- Prepare a concise cover letter explaining novelty and relevance to JAPST.
- Include ethical approvals, trial registration, and informed consent where applicable.
- Provide a data availability statement and cite datasets or code repositories.
- Disclose funding sources and potential conflicts of interest.
- Use clear tables and figures with descriptive captions.
Author support and language editing
JAPST offers optional language editing and pre submission support for authors who want additional clarity and polish before peer review. These services are independent of editorial decisions and do not guarantee acceptance, but they can improve readability and reduce revision cycles.
Learn more about the Language Editing Service or contact [email protected] for guidance.
Article processing charges and support
JAPST operates under a transparent APC model. The standard article processing charge is $2100 USD and is invoiced only after acceptance. We offer membership discounts and need based waivers for eligible authors.
See the APC page for details on waivers, student rates, and institutional support.
Ready to submit your manuscript?
Join JAPST and share pharmaceutical discoveries that shape practice, policy, and patient outcomes.
